Skip to main content
. 2020 Jul 10;18(3):1559325820936161. doi: 10.1177/1559325820936161

Figure 2.

Figure 2.

Passive targeting of nanoparticles (NPs) to tumor cells. NPs (yellow) can accumulate in the tumor stroma, enhancing the lethality of tumor cells and reducing the systemic toxicity of chemotherapy. Free anticancer drugs (blue) do not have the ability to passively target and will spill over to serious side effects caused by healthy tissues.44